The ATM agreement is now live, meaning FSI can begin selling shares into the market at any time. Monitor daily volume and price action for signs of ATM execution — elevated volume with price weakness would suggest active selling. The prior 424B5 flagged up to 21% dilution; actual dilution depends on the pace and price of sales. Watch for quarterly 10-Q disclosures of shares sold under the ATM.
Price Chart
Executive Summary
Flexible Solutions International (FSI) entered into an ATM Sales Agreement with Bancroft Capital LLC on June 30, 2026, to sell up to $18.5 million of common stock at-the-market. This formalizes the equity offering program that was previously disclosed in the 424B5 prospectus supplement filed two days prior, which already flagged up to 21% potential dilution. The filing is a routine contractual step to implement the ATM program, but the proximity to the prior capital raise disclosure confirms the company is actively pursuing equity financing.
Key Facts
- FSI entered into an ATM Sales Agreement with Bancroft Capital LLC on June 30, 2026, to sell up to $18.5 million of common stock at-the-market.
- The ATM agreement formalizes the equity offering program previously disclosed in the 424B5 prospectus supplement filed July 1, 2026.
- The prior 424B5 filing flagged potential dilution of up to 21% based on current shares outstanding.
- Sales Agent receives 3% of gross proceeds as compensation; company reimburses up to $30,000 in expenses plus up to $5,000/quarter.
- The shelf registration statement (Form S-3) was declared effective March 5, 2026, with a total capacity of $50 million.
Financial Impact
Up to $18.5 million in gross proceeds from ATM sales; 3% agent fee ($555k at max) plus expense reimbursements. Potential dilution of up to ~21% based on current shares outstanding per the prior 424B5 analysis.
Risk Factors
- Potential dilution of up to ~21% from the $18.5M ATM program, with no specific use of proceeds disclosed beyond working capital.
- ATM sales can be executed at any time, creating persistent overhang on the stock price.
- The 424B5 filed 2 days prior was rated bearish (impact 6), and this 8-K formalizes the same program — the bearish overhang is now active.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-031474 |
| Exhibit: ex5-1.htm | 0001493152-26-031474 |
| Exhibit: ex23-1.htm | 0001493152-26-031474 |
| Document: form8-k.htm | 0001493152-26-031474 |
| Document: 0001493152-26-031474-index-headers.html | 0001493152-26-031474 |
| Document: 0001493152-26-031474-index.html | 0001493152-26-031474 |
| Document: 0001493152-26-031474.txt | 0001493152-26-031474 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 7d ago | Press Release | $6.31 $6.36 | ▲ +0.76% | ▲ +0.91% | $6.26 (−0.79%) |
Oct 6, 2026 20d ago | DEF 14A | $6.28 $6.01 | ▼ −4.30% | ▼ −3.32% | $6.26 (−0.32%) |
Sep 1, 2026 7w ago | 8-K | $5.78 $5.70 | ▼ −1.38% | ▼ −1.47% | $6.26 (+8.30%) |
Aug 18, 2026 9w ago | 8-K | $5.25 $5.50 | ▼ −4.76% | ▼ −4.96% | $6.26 (−19.24%) |
Aug 14, 2026 10w ago | Press Release | $5.39 $5.30 | ▲ +1.67% | ▲ +0.48% | $6.26 (−16.14%) |
Jul 20, 2026 14w ago | Press Release | $5.22 $5.00 | ▲ +4.21% | ▲ +2.99% | $6.26 (−19.92%) |
Jul 1, 2026 16w ago | 8-K | $6.56 $5.96 | ▲ +9.15% | ▲ +9.41% | $6.26 (+4.57%) |
Jul 1, 2026 16w ago | 424B5 | $6.56 $5.96 | ▲ +9.15% | ▲ +9.41% | $6.26 (+4.57%) |
Jun 8, 2026 20w ago | 8-K | $6.40 $6.37 | ▼ −0.47% | ▼ −2.58% | $6.26 (−2.19%) |
May 18, 2026 23w ago | 8-K | $6.10 $6.44 | ▲ +5.57% | ▲ +3.96% | $6.26 (+2.62%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers